Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study

Author： Tan Hiangkiat   Tomic Karen   Hurley Dana   Daniel Gregory   Barron Rich   Malin Jen  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.27, Iss.1, 2011-01, pp. : 79-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Frequency of Febrile Neutropenia in Breast Cancer Patients Receiving Epirubicin and Docetaxel/Paclitaxel with Colony-Stimulating Growth Factors: A Comparison of Filgrastim or Lenograstim with Pegfilgrastim

By  

Oncology, Vol. 70, Iss. 4, 2006-10 ,pp. : 290-293

Karger

Access to resources Recommend Favorite

Comparison of Low-Dose versus Standard-Dose Colony Stimulating Factor in Patients with Chemotherapy-Induced Febrile Neutropenia

By  

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 283-284

Karger

Access to resources Recommend Favorite

A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia

By Dulisse Brian  

Journal of Medical Economics, Vol. 16, Iss. 6, 2013-06 ,pp. : 720-735

Informa Healthcare

Access to resources Recommend Favorite

Burden of febrile neutropenia in the Netherlands

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 2, 2015-03 ,pp. : 232-241

John Wiley & Sons Inc

Access to resources Recommend Favorite

Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain

By Mayordomo José Ignacio   López Andrés   Viñolas Núria   Castellanos Javier   Pernas Sonia   Domingo Alonso Juan   Frau Adolfo   Layola Miquel   Antonio Gasquet José   Sánchez Jordi  

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2533-2542

Informa Healthcare

Access to resources Recommend Favorite